SIROP DM 15 MG / 5 ML — DIN 02277336
DEXTROMETHORPHAN HYDROBROMIDE : 15 MG / 5 ML · PHARMALAB INC. · SYRUP · wholesale supply in Canada
Health Canada status: CANCELLED PRE MARKET
What is SIROP DM?
SIROP DM 15 MG / 5 ML contains DEXTROMETHORPHAN HYDROBROMIDE : 15 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02277336, held by PHARMALAB INC., supplied as SYRUP for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 27-Jul-2022. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Dextromethorphan cost around the world?
Dextromethorphan is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Romania publishes a max producer price; Saudi Arabia publishes a public; South Africa publishes a single exit price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 12 | 12 | SAR███.██ |
| Romania | max producer price | 5 | 8 | RON███.██ |
| South Africa | single exit price | 2 | 3 | ZAR███.██ |
| United States | acquisition | 1 | 1 | USD███.██ |
24 pack listings across 20 brand entries and 4 price bases, refreshed 10 Sep 2026. Ranges span every Dextromethorphan pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Dextromethorphan in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
37 holders have a Canadian DIN containing Dextromethorphan, across 84 DINs, of which 10 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 5 | 3 | BALMINIL DM, BALMINIL DM (3MG/ML SUCROSE FREE), DM SYRUP (SUCROSE FREE), KOFFEX DM, KOFFEX DM (SUCROSE FREE) | Sourceable in Canada |
| MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | 14 | 2 | BENYLIN DM 12 HOUR SYRUP, BENYLIN DM EXTRA STRENGTH LOZENGES, BENYLIN DM FREEZER POPS, BENYLIN DM LIQUID CENTRE LOZENGES, BENYLIN DM LIQUID CENTRE LOZENGES EXTRA STRENGTH, +9 more | Sourceable in Canada |
| HALEON CANADA ULC | 2 | 2 | BUCKLEY'S DRY COUGH EXTRA STRENGTH, ROBITUSSIN DM COUGHGELS LIQUI-GELS TOUX | Sourceable in Canada |
| PROCTER & GAMBLE INC | 4 | 1 | DAYQUIL KIDS HONEY, VICKS CUSTOM CARE DRY COUGH, VICKS DAYQUIL COUGH, VICKS PEDIATRIC FORMULA 44 LIQ | Sourceable in Canada |
| CRLS | 1 | 1 | DRY COUGH RELIEF EXTRA STRENGTH | Sourceable in Canada |
| LABORATOIRE ATLAS INC | 1 | 1 | BRONCHOPHAN FORTE DM SYR | Sourceable in Canada |
| NOVARTIS CONSUMER HEALTH CANADA INC. | 5 | 0 | DELSYM DM SUSPENSION 30MG/5ML, NEOCITRAN THIN STRIPS COUGH, TRIAMINIC DM, TRIAMINIC LONG ACTING COUGH, TRIAMINIC SOFTCHEWS COUGH | No marketed DIN |
| CELLCHEM PHARMACEUTICALS INC. | 4 | 0 | CHILDREN'S COUGH SYRUP, DRY COUGH CAPSULES, DRY COUGH SYRUP, TICKLY THROAT COUGH SYRUP | No marketed DIN |
| TECHNILAB PHARMA INC. | 4 | 0 | BRONCHO-GRIPPOL-DM, CALMYLIN NO. 1 SYR 15MG/5ML, DM COUGH SYRUP 15MG/5ML, KOFFEX DM CHILDREN | No marketed DIN |
| THERAPEX DIVISION DE E-Z-EM CANADA INC | 4 | 0 | PHARMILIN-DM SYR 15MG/5ML, PHARMINIL DM SUGAR-FREE LIQ 15MG/5ML, PHARMINIL DM SYR 15MG/5ML, SYRUP DM - 15MG/5ML | No marketed DIN |
| ROUGIER PHARMA DIVISION OF RATIOPHARM INC | 3 | 0 | BALMINIL DM CHILDREN, BALMINIL DM POUR ENFANTS SYR 7.5MG/5ML, KOFFEX DM POUR ENFANTS SYR 7.5MG/ML | No marketed DIN |
| TRILLIUM HEALTH CARE PRODUCTS INC | 3 | 0 | DM CHILDREN'S COUGH SYRUP, DM COUGH SYRUP, DRY COUGH RELIEF EXTRA STRENGTH | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 15 MG / 5 ML |
|---|---|
| Dosage form | SYRUP |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Dextromethorphan |
|---|---|
| ATC code | R05DA09 |
| AHFS class | 48:08.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02277336 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2277336 |
| Brand name | SIROP DM |
| Generic / active ingredient | DEXTROMETHORPHAN HYDROBROMIDE : 15 MG / 5 ML |
| Market authorization holder | PHARMALAB INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R05DA09 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R05DA |
| Current status | CANCELLED PRE MARKET |
| Status date | 27-Jul-2022 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
10 of 84 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| BALMINIL DM (3MG/ML SUCROSE FREE) | 15 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | 01928775 |
| BENYLIN EXTRA STRENGTH DRY COUGH | 30 MG / 10 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 01944738 |
| BENYLIN FOR CHILDREN DRY COUGH | 7.5 MG / 5 ML | SOLUTION | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02215268 |
| BRONCHOPHAN FORTE DM SYR | 15 MG / 5 ML | SYRUP | LABORATOIRE ATLAS INC | MARKETED | 00522791 |
| BUCKLEY'S DRY COUGH EXTRA STRENGTH | 15 MG / 5 ML | SOLUTION | HALEON CANADA ULC | MARKETED | 02511320 |
| DAYQUIL KIDS HONEY | 10 MG / 15 ML | SYRUP | PROCTER & GAMBLE INC | MARKETED | 02549360 |
| DRY COUGH RELIEF EXTRA STRENGTH | 30 MG / 10 ML | SYRUP | CRLS | MARKETED | 02534754 |
| KOFFEX DM | 15 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | 01928783 |
| KOFFEX DM (SUCROSE FREE) | 15 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | 01928791 |
| ROBITUSSIN DM COUGHGELS LIQUI-GELS TOUX | 15 MG | CAPSULE | HALEON CANADA ULC | MARKETED | 02252554 |
2 · Same class — other molecules in ATC R05DA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Combinations | ACTIFED DM SYRUP · ACTIFED DM TABLETS · ANTITUSSIVE DECONG ANTIHISTAMINE SYR · BALMINIL DM + DECONGESTANT · +146 more | 165 | 11 | Yes |
| Dextromethorphan | ADULT HONEY WORKS · BALMINIL DM · BALMINIL DM (3MG/ML SUCROSE FREE) · BALMINIL DM CHILDREN · +75 more | 84 | 10 | Yes |
| Codeine | CODEINE 15 · CODEINE 30 · CODEINE CONTIN 100MG CONTROLLED RELEASE TAB · CODEINE CONTIN 150MG CONTROLLED RELEASE TAB · +17 more | 24 | 9 | Yes |
| Hydrocodone | HYCODAN SYRUP · HYCODAN TABLETS · PDP-HYDROCODONE · ROBIDONE 1MG/ML SYR · +1 more | 5 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R05D
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R05DB | Clofedanol | 1 | 1 |
4 · Fixed-dose combinations with Canadian supply
| Product | Active ingredients | Holder | Status | DIN |
|---|---|---|---|---|
| CODEINE CONTIN 100MG CONTROLLED RELEASE TAB | CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE) : 100 MG | PURDUE PHARMA | MARKETED | 02163748 |
| CODEINE CONTIN 150MG CONTROLLED RELEASE TAB | CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE) : 150 MG | PURDUE PHARMA | MARKETED | 02163780 |
| CODEINE CONTIN 200MG CONTROLLED RELEASE TAB | CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE) : 200 MG | PURDUE PHARMA | MARKETED | 02163799 |
| CODEINE CONTIN 50MG CONTROLLED RELEASE TAB | CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE) : 50 MG | PURDUE PHARMA | MARKETED | 02230302 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is SIROP DM called?
The same molecule, Dextromethorphan, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Flustat | Latin | South Africa |
| Benylin Dmd | Latin | South Africa |
| KAFOSED G SYRUP | Latin | Saudi Arabia |
| ROBITUSSIN-DM SYRUP | Latin | Saudi Arabia |
| ROMILAR EXP SYRUP | Latin | Saudi Arabia |
| TUSSILAR TAB | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Dextromethorphan called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Dextromethorphan, published to help those searches reach this page.
| Language | Dextromethorphan |
|---|---|
| German Deutsch | Dextromethorphan |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.